64 related articles for article (PubMed ID: 36625956)
1. A simple in-host model for COVID-19 with treatments: model prediction and calibration.
Al-Darabsah I; Liao KL; Portet S
J Math Biol; 2023 Jan; 86(2):20. PubMed ID: 36625956
[TBL] [Abstract][Full Text] [Related]
2. Within Host Dynamics of SARS-CoV-2 in Humans: Modeling Immune Responses and Antiviral Treatments.
Ghosh I
SN Comput Sci; 2021; 2(6):482. PubMed ID: 34661166
[TBL] [Abstract][Full Text] [Related]
3. A multiscale multicellular spatiotemporal model of local influenza infection and immune response.
Sego TJ; Mochan ED; Ermentrout GB; Glazier JA
J Theor Biol; 2022 Jan; 532():110918. PubMed ID: 34592264
[TBL] [Abstract][Full Text] [Related]
4. Modeling viral dynamics in SARS-CoV-2 infection based on differential equations and numerical analysis.
Odaka M; Inoue K
Heliyon; 2021 Oct; 7(10):e08207. PubMed ID: 34693064
[TBL] [Abstract][Full Text] [Related]
5. Mathematical modeling of COVID-19 pandemic in the context of sub-Saharan Africa: a short-term forecasting in Cameroon and Gabon.
Nkwayep CH; Bowong S; Tsanou B; Alaoui MAA; Kurths J
Math Med Biol; 2022 Feb; 39(1):1-48. PubMed ID: 35045180
[TBL] [Abstract][Full Text] [Related]
6. Within-host dynamics of SARS-CoV-2 infection: A systematic review and meta-analysis.
Du Z; Wang S; Bai Y; Gao C; Lau EHY; Cowling BJ
Transbound Emerg Dis; 2022 Nov; 69(6):3964-3971. PubMed ID: 35907777
[TBL] [Abstract][Full Text] [Related]
7. Modeling the stochastic within-host dynamics SARS-CoV-2 infection with discrete delay.
Elbaz IM; Sohaly MA; El-Metwally H
Theory Biosci; 2022 Nov; 141(4):365-374. PubMed ID: 36190645
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of viral infection dynamics and immune response in SARS-CoV-2: A computational framework for testing drug efficacy.
Sharma S; Saxena A; Chel S; Mitra K; Giri L
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4370-4373. PubMed ID: 34892188
[TBL] [Abstract][Full Text] [Related]
9. Forecasting the daily and cumulative number of cases for the COVID-19 pandemic in India.
Khajanchi S; Sarkar K
Chaos; 2020 Jul; 30(7):071101. PubMed ID: 32752627
[TBL] [Abstract][Full Text] [Related]
10. Simple mathematical models do not accurately predict early SIV dynamics.
Noecker C; Schaefer K; Zaccheo K; Yang Y; Day J; Ganusov VV
Viruses; 2015 Mar; 7(3):1189-217. PubMed ID: 25781919
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
[TBL] [Abstract][Full Text] [Related]
12. Computational simulations to dissect the cell immune response dynamics for severe and critical cases of SARS-CoV-2 infection.
Blanco-Rodríguez R; Du X; Hernández-Vargas E
Comput Methods Programs Biomed; 2021 Nov; 211():106412. PubMed ID: 34610492
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive compartmental model and calibration algorithm for the study of clinical implications of the population-level spread of COVID-19: a study protocol.
Robinson B; Edwards JD; Kendzerska T; Pettit CL; Poirel D; Daly JM; Ammi M; Khalil M; Taillon PJ; Sandhu R; Mills S; Mulpuru S; Walker T; Percival V; Dolean V; Sarkar A
BMJ Open; 2022 Mar; 12(3):e052681. PubMed ID: 35273043
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
16. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
17. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response.
Hattaf K; Yousfi N
Math Biosci Eng; 2020 Aug; 17(5):5326-5340. PubMed ID: 33120555
[TBL] [Abstract][Full Text] [Related]
19. Modelling the transmission of infectious diseases inside hospital bays: implications for COVID-19.
Martos DM; Parcell BJ; Eftimie R
Math Biosci Eng; 2020 Nov; 17(6):8084-8104. PubMed ID: 33378934
[TBL] [Abstract][Full Text] [Related]
20. Data-driven multi-scale mathematical modeling of SARS-CoV-2 infection reveals heterogeneity among COVID-19 patients.
Wang S; Hao M; Pan Z; Lei J; Zou X
PLoS Comput Biol; 2021 Nov; 17(11):e1009587. PubMed ID: 34818337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
